2care4 Generics ApS: Financial statements 2020
CVR: 36960566
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
2care4 Generics ApS (CVR 36960566) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 32,852,182 and a net result of DKK 15,714,624 compared with DKK -599,230 the year before. That is an increase of 311.2% compared with the year before. Equity in the 2020 report amounted to DKK 15,549,059. The solvency ratio was 21.5%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 32,852,182
- Profit/Loss
- DKK 15,714,624
- Equity
- DKK 15,549,059
- Total Assets
- DKK 72,432,512
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 32.9 mio. | 15.7 mio. | 15.5 mio. | 12 |
| 2019 | - | 8 mio. | -599 t. | -166 t. | 8 |
| 2018 | - | 3.3 mio. | -2.9 mio. | 434 t. | 7 |
| 2017 | - | -1.5 mio. | -6 mio. | 330 t. | 5 |
Official annual report
How creditworthy is 2care4 Generics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
2care4 Generics ApS has published its annual report for 2019. Gross profit came to DKK 7,988,765, and the net result was DKK -599,230.
About 2care4 Generics ApS
2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The board consists of Toke Værndal. The company is owned by 2care4 Group ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity in the 2025 report amounted to DKK 49,944,000.